Astellas Pharma Inc. (ALPMF)
OTCMKTS
· Delayed Price · Currency is USD
9.61
0.00 (0.00%)
Jul 2, 2025, 4:00 PM EDT
Astellas Pharma Employees
Astellas Pharma had 13,643 employees as of March 31, 2025. The number of employees decreased by 1,111 or -7.53% compared to the previous year.
Employees
13,643
Change (1Y)
-1,111
Growth (1Y)
-7.53%
Revenue / Employee
$936,031
Profits / Employee
$24,839
Market Cap
17.32B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Elite Pharmaceuticals | 64 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| Silence Therapeutics | 116 |
Astellas Pharma News
- 20 days ago - Mitsubishi Research Institute and Astellas Announce Collaboration to Support Pharma Startups in Japan - PRNewsWire
- 20 days ago - Lupin shares in focus after US Court rejects plea in Astellas Patent case - Business Upturn
- 4 weeks ago - Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug Conjugate Targeting CLDN18.2 - PRNewsWire
- 5 weeks ago - Astellas Announces Second Annual Patient Advocacy Organization (PAO) Action Week™ To Empower Patients and Caregivers - PRNewsWire
- 5 weeks ago - Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer - Benzinga
- 6 weeks ago - Astellas and MBC BioLabs Announce the 2025 Astellas Future Innovator Prize Awarded to DeepSeq.AI & Serna Bio - PRNewsWire
- 2 months ago - Astellas to Present New Data in Geographic Atrophy at Upcoming Ophthalmology Annual Congresses - PRNewsWire
- 2 months ago - Astellas Pharma Inc. (ALPMF) Q4 2024 Earnings Call Transcript - Seeking Alpha